Healthcare provider profile · identity verified

James J Schlichtmann, M.D.

Family Practice · WASHINGTON, IA · NPI 1104868348

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	502	102
Rosuvastatin Calcium	Rosuvastatin Calcium	456	90
Losartan Potassium	Losartan Potassium	374	84
Atorvastatin Calcium	Atorvastatin Calcium	339	78
Amlodipine Besylate	Amlodipine Besylate	307	74
Pantoprazole Sodium	Pantoprazole Sodium	276	54
Metoprolol Succinate	Metoprolol Succinate	275	73
Omeprazole	Omeprazole	266	63
Furosemide	Furosemide	260	50
Lisinopril	Lisinopril	255	64
Potassium Chloride	Potassium Chloride	245	45
Gabapentin	Gabapentin	213	44
Spironolactone	Spironolactone	188	33
Montelukast Sodium	Montelukast Sodium	183	48
Eliquis	Apixaban	167	26
Tamsulosin Hcl	Tamsulosin Hcl	166	34
Metoprolol Tartrate	Metoprolol Tartrate	165	37
Glimepiride	Glimepiride	150	36
Famotidine	Famotidine	138	42
Tramadol Hcl	Tramadol Hcl	134	31
Metformin Hcl Er	Metformin Hcl	133	35
Warfarin Sodium	Warfarin Sodium	125	21
Trazodone Hcl	Trazodone Hcl	121	22
Cefdinir	Cefdinir	118	78
Hydrochlorothiazide	Hydrochlorothiazide	99	27
Prednisone	Prednisone	98	63
Sertraline Hcl	Sertraline Hcl	98	18
Simvastatin	Simvastatin	96	20
Escitalopram Oxalate	Escitalopram Oxalate	91	16
Duloxetine Hcl	Duloxetine Hcl	89	16
Allopurinol	Allopurinol	88	25
Azithromycin	Azithromycin	87	60
Alprazolam	Alprazolam	77	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	77	12
Celecoxib	Celecoxib	71	17
Metformin Hcl	Metformin Hcl	70	19
Terazosin Hcl	Terazosin Hcl	69	15
Pravastatin Sodium	Pravastatin Sodium	68	16
Meloxicam	Meloxicam	66	17
Albuterol Sulfate Hfa	Albuterol Sulfate	65	17
Clopidogrel	Clopidogrel Bisulfate	61	17
Hydroxyzine Hcl	Hydroxyzine Hcl	60	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	15
Clonazepam	Clonazepam	59	suppressed
Finasteride	Finasteride	58	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	18
Lorazepam	Lorazepam	50	suppressed
Carvedilol	Carvedilol	48	14
Mirtazapine	Mirtazapine	48	suppressed
Mupirocin	Mupirocin	47	24
Atenolol	Atenolol	46	11
Doxycycline Monohydrate	Doxycycline Monohydrate	46	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Xarelto	Rivaroxaban	45	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Torsemide	Torsemide	42	11
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	12
Tresiba Flextouch U-200	Insulin Degludec	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Ipratropium Bromide	Ipratropium Bromide	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Baclofen	Baclofen	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Bumetanide	Bumetanide	33	13
Fluticasone Propionate	Fluticasone Propionate	33	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Levetiracetam	Levetiracetam	29	suppressed
Temazepam	Temazepam	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Pentoxifylline	Pentoxifylline	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Amoxicillin	Amoxicillin	20	11
Clonidine Hcl	Clonidine Hcl	20	suppressed
Ozempic	Semaglutide	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Levofloxacin	Levofloxacin	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	12
Fluconazole	Fluconazole	18	11
Jardiance	Empagliflozin	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Febuxostat	Febuxostat	17	suppressed
Sulfasalazine	Sulfasalazine	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nitroglycerin	Nitroglycerin	16	13
Prazosin Hcl	Prazosin Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Novolog	Insulin Aspart	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Diazepam	Diazepam	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Glipizide	Glipizide	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error